CEO of Fi-Med, Mr Adrian Velasquez said “I have wanted to...

CEO of Fi-Med, Mr Adrian Velasquez said “I have wanted to provide RPM to our patient base for years. However, the ordering, distribution, installation, patient training and cost have been prohibitive until we met Respiri. The collaboration with Respiri is truly exciting for us. By leveraging Respiri's groundbreaking device, wheezo®, and its integrated technology, we foresee a rapid growth in patients under management and also growth in monthly billable events per patient. We look forward to working collaboratively with Marjan and his team over the coming years to establish our shared approach and deliver substantial value to our respective customers.

Announcement like this and the shares still around 3 Cents - just crazy!